Primary experimental recordNegative / threshold

PMC10043419::ACT000063

MPI-C

Evidence text

Paper-level observation

After incubation ... the calculated hemolysis ratio of OMV groups was lower than 5% (Figures 5A, B), indicating the negligible hemolysis caused by bioengineered OMVs in vitro.

figureConfidence: medium

Assay observation

Activity

Toxicity

Subtype

Hemolytic

Measure

hemolysis

Comparator

Raw observation

<5%

Normalized measurement

?–5%

Value minimum

Not reported by source

Value maximum

Target

Mus musculus

Assay method

Not reported by source

Sequence

Not reported by source

Standardization

insufficient information

Source publication

Bioengineered bacterial outer membrane vesicles encapsulated Polybia–mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy

Frontiers in Immunology · 2023

DOI 10.3389/fimmu.2023.1129771 PMC10043419

Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.